1
Kishi T.Short-term adjunct of topiramate to antipsychotics in schizophrenia improves the psychopathology and has weight maintenance.
Evid Based Ment Health. 2017 May;20(2):61.
2
Taro Kishi, Ken Inada, Yuki Matsui, Nakao Iwata.
Z-drug for schizophrenia: A systematic review and meta-analysisPsychiatry Research
Volume 256, October 2017, Pages 365-370
3
M Ikeda, A Takahashi, Y Kamatani, Y Okahisa, H Kunugi, N Mori, T Sasaki, T Ohmori, Y Okamoto, H Kawasaki, S Shimodera, T Kato, H Yoneda, R Yoshimura, M Iyo, K Matsuda, M Akiyama, K Ashikawa, K Kashiwase, K Tokunaga, K Kondo, T Saito, A Shimasaki, K Kawase, T Kitajima, K Matsuo, M Itokawa, T Someya, T Inada, R Hashimoto, T Inoue, K Akiyama, H Tanii, H Arai, S Kanba, N Ozaki, I Kusumi, T Yoshikawa, M Kubo & N Iwata for the advanced Collaborative Study of Mood Disorder (COSMO) team.
A genome-wide association study identifies two novel susceptibility loci and trans population polygenicity associated with bipolar disorder
Molecular Psychiatry (2018) 23, 639–647
4
Yuichi Esaki, Tsuyoshi Kitajima, Hiroshige Fujishiro, Shiho Fujita, Marina Hirose, Akiko Watanabe, Nakao Iwata.
Parasomnia overlap disorder caused by paroxetine
Sleep and Biological Rhythms
October 2017, Volume 15, Issue 4, pp 327–329
5
Taro Kishi, Yuki Matsuda, Nakao Iwata
Memantine add-on to antipsychotic treatment for residual negative and cognitive symptoms of schizophrenia: a meta-analysis
Psychopharmacology
July 2017, Volume 234, Issue 14, pp 2113–2125
6
Kishi, Taroa, Matsunaga, Shinjia, Oya, Kazutoa, Nomura, Ikuoa, Ikuta, Toshikazub, Iwata, Nakao.
Memantine for Alzheimer’s Disease: An Updated Systematic Review and Meta-analysis
Journal of Alzheimer's Disease, vol. 60, no. 2, pp. 401-425, 2017
7
Taro Kishi,Shinji Matsunaga, Nakao Iwata
The effects of memantine on behavioral disturbances in patients with Alzheimer's disease: a meta-analysis
Neuropsychiatric Disease and Treatment Volume 2017:13 Pages 1909—1928
8
Taro Kishi, Toshikazu Ikuta, Shinji Matsunaga, Yuki Matsuda, Kazuto Oya, Nakao Iwata
Comparative Efficacy and Safety of Antipsychotics in the Treatment of Schizophrenia: a Network Meta-analysis in a Japanese Population
Neuropsychiatric Disease and Treatment Volume 2017:13 Pages 1281—1302
9
Akiko Watanabe, Marina Hirose, Tsuyoshi Kitajima, Satoe Tomita, Yuichi Esaki, Nakao Iwata
A retrospective study of the efficacy of ramelteon for insomnia: Relevance to dose and timing of administration
Sleep and Biological Rhythms January 2018, Volume 16, Issue 1, pp 69–75
10
Ikeda M, Saito T, Kondo K, Iwata N.
Genome-wide association studies of bipolar disorder: A systematic review of recent findings and their clinical implications.
Psychiatry Clin Neurosci. 2018 Feb;72(2):52-63.
11
Takeo Saito, Masashi Ikeda, Ryota　Hashimoto(Clozapine Pharmacogenomics Consortium of Japan), Nakao Iwata.
Transethnic Replication Study to Assess the Association Between Clozapine-Induced Agranulocytosis/Granulocytopenia and Genes at 12p12.2 in a Japanese Population
Biological Psychiatry Volume 82, Issue 1, 1 July 2017, Pages e9-e10
12
Taro Kishi, Toshikazu Ikuta, Yuki Matsuda, Nakao Iwata
Response to the letter from Dr. Veerman and colleagues.
Psychopharmacology December 2017, Volume 234, Issue 23–24, pp 3537–3538